TUG1 and hepatocellular carcinoma: Moreover, siRNA downregulation of TUG1 expression shows antitumor activity in HCC cells by suppressing tumor progression, such as proliferation, migration, and invasion, as well as by enhancing the T cell-induced immune response both in vitro and in vivo.